Universal flu vaccine edging closer to realityApril 28th, 2009 - 3:52 pm ICT by IANS
Washington, April 28 (IANS) An influenza vaccine that protects against death and serious complications from different strains of flu is edging closer to reality.
“This is a significant first step in developing a universal vaccine to help protect against pandemic influenza,” said Robert Belshe, director of the Saint Louis University Centre for Vaccine Development (SLUCVD).
Currently drug companies manufacture a different flu vaccine each year to match the strains of influenza that researchers predict will circulate. Adding a universal influenza vaccine to a seasonal vaccine would help improve protection against strains of influenza as they change each year.
“Novel vaccines, capable of inducing long-lasting, broad immunity against divergent strains, including potential pandemic viruses, are highly desirable,” Belshe said.
In the study, 377 healthy adults received three injections of a universal influenza vaccine, known as Bivalent Influenza Peptide Conjugate Vaccine (BIPCV), over a six-month period.
Researchers found that a low dose of the vaccine is well tolerated and safe, Belshe said. It addition, the low dose vaccine evoked an immune response - high antibody titers - that is similar to levels associated with protecting small animals infected with influenza from serious disease and death. More testing is needed, Belshe added.
The research also is significant in light of the search for a vaccine to protect against a deadly influenza pandemic, which is a global outbreak of the disease that spreads quickly with lethal consequences, said an SLUCVD release.
Belshe presented his findings Monday at the National Foundation for Infectious Disease Conference for Vaccine Research in Baltimore.
- Universal influenza vaccine comes closer to reality - Apr 28, 2009
- H1N1 pandemic flu strain 'key to universal vaccine' - Jan 11, 2011
- Effective antibodies against flu strains identified - Aug 10, 2012
- Nasal spray flu vaccine one step closer - Feb 18, 2011
- Scientists explore 1510 influenza pandemic and lessons learned - Nov 13, 2010
- Universal influenza vaccine 'on the anvil' - Dec 07, 2010
- Novel approach shows great potential in reducing mortality from flu - Apr 23, 2011
- New compound boosts efficacy of HIV, flu vaccine - Aug 27, 2012
- Universal flu vaccine shows promise - Jun 08, 2011
- The reason behind mildness of 2009 H1N1 pandemic - Jun 19, 2010
- Single dose of H1N1 vaccine enough to protect infants, kids - Dec 22, 2009
- Soon, nasal spray vaccines to curb flu - Apr 12, 2011
- Vaccine offers hope to treat chikungunya - Aug 14, 2011
- One-time jab to protect against all flu strains - Nov 16, 2010
- Anthrax shot protects simians from lethal infection - Jan 13, 2012
Tags: antibody titers, conjugate vaccine, flu vaccine, immune response, infectious disease, infectious disease conference, influenza, influenza pandemic, influenza vaccine, lethal consequences, national foundation, novel vaccines, pandemic influenza, peptide, robert belshe, saint louis university, small animals, strains, vaccine development, vaccine research